Company Description
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.
It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products.
It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R.
Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store.
Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.
| Country | Colombia |
| Founded | 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 729 |
| CEO | Forrest Hoffmaster |
Contact Details
Address: 865 N. Albion St., Suite 300 Denver, Colorado 80220 United States | |
| Phone | 303-371-0387 |
| Website | schwazze.com |
Stock Details
| Ticker Symbol | SHWZ |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001622879 |
| CUSIP Number | 58468U106 |
| ISIN Number | US58468U1060 |
| Employer ID | 46-5289499 |
| SIC Code | 8742 |
Key Executives
| Name | Position |
|---|---|
| Daniel R. Pabon | Chief Policy and Regulatory Affairs Officer |
| Forrest Hoffmaster | Chief Financial Officer |
| Christine Jones | Chief Legal Officer |
| Dan Bonach | Vice President of Human Resources |
| Todd Williams | Executive Vice President of M&A and Real Estate |
| Dr. Jim Parco | President of Schwazze Biosciences Ltd. |
| Christopher Lee Driessen | Executive Vice President of Commercial Sales |
| Collin Lodge | President of Colorado Division |
| David Kaufman | Executive Vice President of Integrated Supply Chain |
| Ed Eissenstat | Vice President of Information Technology and C.I.O |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 16, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 15, 2024 | 8-K | Current Report |
| Apr 29, 2024 | ARS | Filing |
| Apr 29, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 29, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 8, 2024 | 8-K | Current Report |
| Apr 3, 2024 | 8-K | Current Report |
| Apr 2, 2024 | SCHEDULE 13G/A | Filing |
| Mar 27, 2024 | 10-K | Annual Report |
| Feb 23, 2024 | 8-K | Current Report |